What is the clinical evidence from this study?

Study design: Other. Population: Refractory cardioinhibitory vasovagal syncope. Intervention: 3D Mapping-Guided Cardioneuroablation.

What does this research mean for the field?

Cardioneuroablation is an effective pacemaker-sparing strategy for refractory cardioinhibitory vasovagal syncope, associated with an overall syncope recurrence rate of 12.5%. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate the effectiveness of cardioneuroablation as a treatment for refractory cardioinhibitory vasovagal syncope.

June 24, 2026Heart Rhythm O2Open Access

3D Mapping-Guided Cardioneuroablation as a Pacemaker-Sparing Strategy in Refractory Cardioinhibitory Vasovagal Syncope: A Brief Report

View Full Paper

Ask AI

Bookmark

Key result

Cardioneuroablation shows ~13% recurrence in refractory vasovagal syncope, emerging as a promising pacemaker-sparing strategy.

Why the study?

Does 3D mapping-guided cardioneuroablation prevent syncope recurrence in young patients with refractory cardioinhibitory vasovagal syncope?

Population

Young patients with cardioinhibitory vasovagal syncope (VVS) refractory to pharmacotherapy

Design

Other

Authors

JNJaouad NGUADIMohammed V University HBHicham BouzelmatMohammed V University MGMehdi GUEDIRAMelun Hospital

Discussion

Member takes

Implication

May spare pacemakers in refractory cardioinhibitory vasovagal syncope; leaves long-term durability open.

Key Points

To evaluate the effectiveness of cardioneuroablation as a treatment for refractory cardioinhibitory vasovagal syncope.
Conducted an updated meta-analysis of 37 studies
Analyzed data from 1,585 patients
Focused on syncope recurrence rates post-intervention.
Reported an overall syncope recurrence rate of 12.5%
Median follow-up across studies was often less than 12 months
Limited long-term recurrence data.

Structured PICO

Does 3D mapping-guided cardioneuroablation prevent syncope recurrence in young patients with refractory cardioinhibitory vasovagal syncope?

Population

Young patients with cardioinhibitory vasovagal syncope (VVS) refractory to pharmacotherapy

Intervention

3D mapping-guided cardioneuroablation (catheter-based selective denervation of cardiac parasympathetic ganglia)

Cardioneuroablation is highlighted as a promising pacemaker-sparing strategy for refractory cardioinhibitory vasovagal syncope, though long-term recurrence data remain limited.

Limitations

Median follow-up across included studies often does not exceed 12 months
Long-term recurrence data remain limited in scope

Cite This Study

NGUADI et al. (2026) studied Refractory cardioinhibitory vasovagal syncope. 3D Mapping-Guided Cardioneuroablation was evaluated. Cardioneuroablation for refractory cardioinhibitory vasovagal syncope is a promising pacemaker-sparing strategy, with a cited meta-analysis of 1,585 patients reporting a 12.5% recurrence rate.

synapsesocial.com/papers/6a3c2364d15afadd906fa14f https://doi.org/10.1016/j.hroo.2026.05.018

View Full Paper

Ask AI

Bookmark

3D Mapping-Guided Cardioneuroablation as a Pacemaker-Sparing Strategy in Refractory Cardioinhibitory Vasovagal Syncope: A Brief Report

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

3D Mapping-Guided Cardioneuroablation as a Pacemaker-Sparing Strategy in Refractory Cardioinhibitory Vasovagal Syncope: A Brief Report

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider